1. GSK allies with Innovax for COVID-19 vaccine R&D project— Zentalis Pharma raises $165M in IPO — Drug discovery in the age of coronavirus — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

New QFT

Discussion in 'Oxford Immunotec' started by Anonymous, Jan 9, 2015 at 11:44 AM.

  1. Anonymous

    Anonymous Guest

    Gonna kick y'all's ass as long as the three dumbasses are running sales.
     
  2. Anonymous

    Anonymous Guest

    Same crap, different packaging. Not scared, no matter who's running the show.

    QFT is flawed by design, and because they test whole blood, it doesn't matter what pretty bow they wrap around it, it's still a crappy product. This forum may have some negativity in it, but I bet the one thing anyone would agree on is that T-SPOT is truly a good product, much better than QFT.
     
  3. Anonymous

    Anonymous Guest

    sounds about right
    name a qiagen acquisition in the past ten years that hasn't been run into the ground
    qiagen is the king of buy low and sell lower
     
  4. Anonymous

    Anonymous Guest

    Hahahahaha!!!! I love how this nerd is talking about blood tests. I'm so happy I am leaving this company. I need a backfill...who wants to live in Atlanta???
     
  5. Anonymous

    Anonymous Guest

    Cellestis had a chance, but Qiagen has sucked the life right out of it.
    Stay tuned, the TB reps will be selling HPV, AmniSure, and KRAS testing before you know it.
     
  6. Anonymous

    Anonymous Guest

    Oxford shoots itself in their foot again.
     
  7. Anonymous

    Anonymous Guest

    Yeah....this Newyork thing is going to bite us in the......bigtime.
     
  8. Anonymous

    Anonymous Guest

    LOL. You use one test in clinical trials and use another(Xtend) in actual patients. Not to mention the human component of looking through microscope and the discrepancies it can cause.

    Sorry bud, T Spot is bound to doom.
     
  9. anonymous

    anonymous Guest

    Not to mention how many people actually make contact with the sample once it's in the lab. The test has limited automation and is at high risk for human error. I was shocked when I saw how the test was run. If one person came into work in a bad mood man o man!!

    Oxford Immunotec ...... Making a me too product that nobody cares about! Smart lol.
     
  10. anonymous

    anonymous Guest

    Look who the morons is now. Quest purchased T-Spot as T-Spot is running QFT into the ground like an Ostrich's head lol